Yu Huang

Yu Huang

Auto-generated profile, based on publicly available information

Yu Huang

Department of Cardiothoracic Surgery, Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
HLHongru Li
Hongru Li
XZXiongpeng Zhu
Xiongpeng Zhu
RYRongguo Yu
Rongguo Yu
XQXin Qian
Xin Qian
YHYu Huang
Yu Huang
HLHong Li
Hong Li
Object: This study attempted to explore the effects of vaccination on disease severity and the factors for viral clearance and hospitalization in omicron-infected patients.Methods: The clinical manifestations of 3,265 Omicron-infected patients (BA.2 lineage variant; the Omicron group) were compared with those of 226 Delta-infected patients (the Delta group). A Multi-class logistic regression model was employed to analyze the impacts of vaccination doses and intervals on disease severity; a logistic regression model to evaluate the risk factors for hospitalization; R 4.1.2 data analysis to investigate the factors for time for nucleic acid negativization (NAN).Results: Compared with the Delta group, the Omicron group reported a fast transmission, mild symptoms, and lower severity incidence, and a significant inverse correlation of vaccination dose with clinical severity (OR: 0.803, 95%CI: 0.742-0.868, p<0.001). Of the 7 or 5 categories of vaccination status, the risk of severity significantly decreased only at ≥21 days after three doses (OR: 0.618, 95% CI: 0.475-0.803, p<0.001; OR: 0.627, 95% CI: 0.482-0.815, p<0.001, respectively). The Omicron group also reported underlying illness as an independent factor for hospitalization, sore throat as a protective factor, and much shorter time for NAN [15 (12,19) vs. 16 (12,22), p<0.05]. NAN was associated positively with age, female gender, fever, cough, and disease severity, but negatively with vaccination doses.Conclusion: Booster vaccination should be advocated for COVID-19 pandemic-related control and prevention policies and adequate precautions should be taken for patients with underlying conditions.

28 February 2025 in International Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
YHYu Huang
Yu Huang
HXHongchun Xu
Hongchun Xu
FXFeng Xiang
Feng Xiang
WFWei Feng
Wei Feng
YMYuchao Ma
Yuchao Ma
LJLongyu Jin
Longyu Jin
Non-steroidal anti-inflammatory drugs (NSAIDs) are increasingly utilized in trauma patients, particularly those with critical chest trauma who are susceptible to significant blood loss, leading to renal hypoperfusion. Acute kidney injury (AKI) is known to carry a poor prognosis in chest trauma patients. Therefore, investigating the potential association between NSAID use and AKI risk in critical patients with chest trauma is crucial. We selected patients admitted to the intensive care unit (ICU) with chest trauma from the Medical Information Mart for Intensive Care III (MIMIC-III) dataset (2001–2012) and the Medical Information Mart for Intensive Care IV (MIMIC-IV) dataset (2013–2019). Propensity score matching (PSM) was used to match patients receiving NSAIDs with those not receiving treatment. Logistic regression was employed to assess the association between different types of NSAIDs and AKI in these patients. In MIMIC-IV, NSAID use significantly increased the risk of AKI in critical patients with chest trauma (OR 1.99; 95% CI 1.04 to 3.85). Subgroup analysis revealed that aspirin significantly increased AKI risk in both MIMIC-III (OR 1.81; 95% CI 1.02 to 3.2) and MIMIC-IV (OR 2.47; 95% CI 1.26 to 4.85). However, ibuprofen and ketorolac use were not associated with AKI in these patients. We observed a significant association between aspirin use and an elevated risk of AKI in critical patients with chest trauma. These findings suggest that pain management strategies involving ibuprofen and ketorolac may be more appropriate for this patient population.

3 July 2026 in Medicine
Verified
Journal Article
Open access
YHYu Huang
Yu Huang
HXHongchun Xu
Hongchun Xu
FXFeng Xiang
Feng Xiang
LJLongyu Jin
Longyu Jin
YCYingji Chen
Yingji Chen
YMYuchao Ma
Yuchao Ma
Accurate localization of small pulmonary nodules during thoracoscopic lung resection remains challenging, and the selection of preoperative localization methods largely relies on surgeon experience. This study aimed to integrate radiomic features and clinical characteristics to develop a data-driven patient clustering approach and to explore the suitability of different preoperative localization methods across patient subgroups. Patients who underwent thoracoscopic wedge resection or segmentectomy with virtual navigation bronchoscopy (VNB) localization, computed tompgraphy (CT)-guided localization, or no localization were retrospectively included. Radiomic features were extracted from preoperative CT images and integrated with clinical and nodule characteristics. Unsupervised K-means clustering was applied. Within each cluster, perioperative outcomes were compared among localization methods. In addition, supervised learning models were constructed to predict cluster assignment and intraoperative blood loss. A total of 925 patients were included, and 3 stable clusters were identified. In Cluster 0, VNB localization was associated with lower intraoperative blood loss than CT-guided localization [wedge resection: 50 (20, 70) ml versus 70 (50, 100) ml, P = .004; segmentectomy: 50 (20, 100) ml versus 100 (50, 100) ml, P = .002]. In Cluster 2, CT-guided localization was associated with lower intraoperative blood loss than VNB localization [wedge resection: 50 (30, 90) ml versus 100 (50, 110) ml, P = .005; segmentectomy: 90 (50, 100) ml versus 105 (85, 170) ml, P = .011], along with a higher localization success rate. The supervised model demonstrated stable performance in predicting cluster assignment (macro-area under the curve = 0.863) and intraoperative blood loss (macro-area under the curve range: 0.813–0.850). VNB localization and CT-guided localization demonstrated distinct advantages across different clusters. These findings support a data-driven, individualized strategy for preoperative localization selection.